questionsmedicales.fr
Facteurs biologiques
Facteurs de la coagulation sanguine
Inhibiteurs d'activateurs du plasminogène
Inhibiteurs d'activateurs du plasminogène : Questions médicales fréquentes
Termes MeSH sélectionnés :
Plastic Surgery Procedures
Diagnostic
5
Thrombose
Échographie
Tests sanguins
Plasminogène
Tests de laboratoire
Activateurs
Embolie pulmonaire
Essoufflement
Douleur thoracique
Saignement
Antécédents médicaux
Tests de coagulation
Thrombose veineuse profonde
Échographie Doppler
Diagnostic
Symptômes
5
Thrombose
Douleur
Gonflement
Angine
Douleur thoracique
Irradiation
Embolie cérébrale
Troubles de la parole
Confusion
Hémorragie interne
Douleur abdominale
Pâleur
Thrombose artérielle
Douleur intense
Perte de pouls
Prévention
5
Prévention
Thromboses
Exercice
Voyages longs
Hydratation
Bas de compression
Risque post-chirurgical
Anticoagulants
Compression
Alimentation
Vitamine K
Anticoagulants
Tabagisme
Thrombose
Agrégation plaquettaire
Traitements
5
Thrombose
Anticoagulants
Thrombolytiques
Inhibiteurs d'activateurs
Plasminogène
Caillots sanguins
Thrombolytiques
Thrombose aiguë
Dissolution des caillots
Anticoagulants
Saignements
Interactions médicamenteuses
Surveillance
Tests sanguins
Coagulation
Complications
5
Complications
Embolie pulmonaire
Insuffisance veineuse
Hémorragie
Anticoagulants
Surveillance
Embolie
Lésions organiques
Douleurs thoraciques
Thrombose
Douleurs chroniques
Problèmes circulatoires
Prévention
Rééducation
Suivi médical
Facteurs de risque
5
Facteurs de risque
Obésité
Antécédents familiaux
Âge
Thrombose
Circulation sanguine
Génétique
Troubles de la coagulation
Thrombose
Contraceptifs
Thrombose
Tabagisme
Hypertension
Vaisseaux sanguins
Thrombose
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs d'activateurs du plasminogène : Questions médicales les plus fréquentes",
"headline": "Inhibiteurs d'activateurs du plasminogène : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Inhibiteurs d'activateurs du plasminogène : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-30",
"dateModified": "2025-03-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Inhibiteurs d'activateurs du plasminogène"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs de la coagulation sanguine",
"url": "https://questionsmedicales.fr/mesh/D001779",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de la coagulation sanguine",
"code": {
"@type": "MedicalCode",
"code": "D001779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.119"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteur-1 d'activateur du plasminogène",
"alternateName": "Plasminogen Activator Inhibitor 1",
"url": "https://questionsmedicales.fr/mesh/D017395",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteur-1 d'activateur du plasminogène",
"code": {
"@type": "MedicalCode",
"code": "D017395",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.119.832.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteur-2 d'activateur du plasminogène",
"alternateName": "Plasminogen Activator Inhibitor 2",
"url": "https://questionsmedicales.fr/mesh/D017396",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteur-2 d'activateur du plasminogène",
"code": {
"@type": "MedicalCode",
"code": "D017396",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.119.832.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs d'activateurs du plasminogène",
"alternateName": "Plasminogen Inactivators",
"code": {
"@type": "MedicalCode",
"code": "D015849",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert J Parmer",
"url": "https://questionsmedicales.fr/author/Robert%20J%20Parmer",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Veterans Administration San Diego Healthcare System, University of California, San Diego, San Diego, CA, United States."
}
},
{
"@type": "Person",
"name": "Lindsey A Miles",
"url": "https://questionsmedicales.fr/author/Lindsey%20A%20Miles",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States."
}
},
{
"@type": "Person",
"name": "Nagyung Baik",
"url": "https://questionsmedicales.fr/author/Nagyung%20Baik",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States."
}
},
{
"@type": "Person",
"name": "Beate Heissig",
"url": "https://questionsmedicales.fr/author/Beate%20Heissig",
"affiliation": {
"@type": "Organization",
"name": "Immunological Diagnosis, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan."
}
},
{
"@type": "Person",
"name": "Koichi Hattori",
"url": "https://questionsmedicales.fr/author/Koichi%20Hattori",
"affiliation": {
"@type": "Organization",
"name": "Center for Genomic & Regenerative Medicine, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Perioperative Medication Management in Elective Plastic Surgery Procedures.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36735455",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/SCS.0000000000009183"
}
},
{
"@type": "ScholarlyArticle",
"name": "Unusual complications at the recipient site following periodontal plastic surgery procedures: a systematic review.",
"datePublished": "2022-07-09",
"url": "https://questionsmedicales.fr/article/35809115",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00784-022-04596-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Can Anti-inflammatory Drugs used in Plastic Surgery Procedures Increase the Risk of Hematoma?",
"datePublished": "2022-11-29",
"url": "https://questionsmedicales.fr/article/36447095",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00266-022-03194-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Do Google Trends Correlate with the Number of Facial Plastic Surgery Procedures Performed in the United States?",
"datePublished": "2022-11-15",
"url": "https://questionsmedicales.fr/article/36379461",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0042-1757474"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Robotics in plastic surgery].",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36625922",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00104-022-01790-w"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Facteurs de la coagulation sanguine",
"item": "https://questionsmedicales.fr/mesh/D001779"
},
{
"@type": "ListItem",
"position": 4,
"name": "Inhibiteurs d'activateurs du plasminogène",
"item": "https://questionsmedicales.fr/mesh/D015849"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Inhibiteurs d'activateurs du plasminogène - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Inhibiteurs d'activateurs du plasminogène",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Inhibiteurs d'activateurs du plasminogène",
"description": "Comment diagnostiquer une thrombose ?\nQuels tests pour évaluer l'activité plasminogène ?\nQuels signes indiquent une embolie pulmonaire ?\nComment évaluer le risque de saignement ?\nQuels examens pour une thrombose veineuse profonde ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Plastic+Surgery+Procedures#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Inhibiteurs d'activateurs du plasminogène",
"description": "Quels sont les symptômes d'une thrombose ?\nComment reconnaître une crise d'angine ?\nQuels signes d'une embolie cérébrale ?\nQuels symptômes d'une hémorragie interne ?\nComment se manifeste une thrombose artérielle ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Plastic+Surgery+Procedures#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Inhibiteurs d'activateurs du plasminogène",
"description": "Comment prévenir les thromboses ?\nQuels conseils pour les voyages longs ?\nComment réduire le risque post-chirurgical ?\nQuels aliments éviter pour prévenir les caillots ?\nComment le tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Plastic+Surgery+Procedures#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Inhibiteurs d'activateurs du plasminogène",
"description": "Quels traitements pour une thrombose ?\nComment agissent les inhibiteurs d'activateurs ?\nQuand utiliser des thrombolytiques ?\nQuels sont les effets secondaires des anticoagulants ?\nComment surveiller l'efficacité du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Plastic+Surgery+Procedures#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Inhibiteurs d'activateurs du plasminogène",
"description": "Quelles sont les complications d'une thrombose ?\nQuels risques d'hémorragie avec les traitements ?\nComment une embolie peut-elle affecter la santé ?\nQuels effets à long terme d'une thrombose ?\nComment prévenir les complications post-thrombose ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Plastic+Surgery+Procedures#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Inhibiteurs d'activateurs du plasminogène",
"description": "Quels sont les facteurs de risque de thrombose ?\nComment l'âge influence-t-il le risque ?\nQuel rôle joue la génétique dans la thrombose ?\nComment les contraceptifs influencent-ils le risque ?\nQuel impact a l'hypertension sur le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Plastic+Surgery+Procedures#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une thrombose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de thrombose se fait par échographie, tests sanguins et évaluation clinique."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'activité plasminogène ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme le dosage du plasminogène et l'activité des activateurs sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une embolie pulmonaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent douleur thoracique, essoufflement et toux avec sang."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque de saignement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'historique médical, les antécédents de saignement et des tests."
}
},
{
"@type": "Question",
"name": "Quels examens pour une thrombose veineuse profonde ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie Doppler est l'examen de choix pour diagnostiquer une TVP."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une thrombose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, gonflement et rougeur dans la zone affectée."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une crise d'angine ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une crise d'angine se manifeste par une douleur thoracique, souvent irradiant vers le bras."
}
},
{
"@type": "Question",
"name": "Quels signes d'une embolie cérébrale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des troubles de la parole, faiblesse d'un côté et confusion."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une hémorragie interne ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure douleur abdominale, faiblesse et pâleur."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une thrombose artérielle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une douleur intense, une pâleur et une perte de pouls dans le membre."
}
},
{
"@type": "Question",
"name": "Comment prévenir les thromboses ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'exercice régulier, l'hydratation et l'évitement de la sédentarité."
}
},
{
"@type": "Question",
"name": "Quels conseils pour les voyages longs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de se lever régulièrement, s'hydrater et porter des bas de compression."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque post-chirurgical ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation d'anticoagulants et de dispositifs de compression aide à réduire le risque."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter pour prévenir les caillots ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments riches en vitamine K, qui peuvent interférer avec les anticoagulants."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme influence-t-il le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme augmente le risque de thrombose en favorisant l'agrégation plaquettaire."
}
},
{
"@type": "Question",
"name": "Quels traitements pour une thrombose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les anticoagulants, les thrombolytiques et la compression."
}
},
{
"@type": "Question",
"name": "Comment agissent les inhibiteurs d'activateurs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils bloquent l'activation du plasminogène, réduisant la dégradation des caillots."
}
},
{
"@type": "Question",
"name": "Quand utiliser des thrombolytiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés en cas de thrombose aiguë pour dissoudre rapidement les caillots."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des anticoagulants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent saignements, ecchymoses et interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance se fait par des tests sanguins réguliers pour évaluer la coagulation."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications d'une thrombose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'embolie pulmonaire, l'insuffisance veineuse et les ulcères."
}
},
{
"@type": "Question",
"name": "Quels risques d'hémorragie avec les traitements ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements anticoagulants augmentent le risque d'hémorragie, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Comment une embolie peut-elle affecter la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une embolie peut entraîner des lésions organiques, des douleurs thoraciques et des décès."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme d'une thrombose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des douleurs chroniques et des problèmes circulatoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications post-thrombose ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rééducation, l'exercice et le suivi médical régulier aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de thrombose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, le tabagisme, l'immobilisation et les antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de thrombose augmente avec l'âge en raison de la diminution de la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans la thrombose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations génétiques peuvent prédisposer à des troubles de la coagulation et à la thrombose."
}
},
{
"@type": "Question",
"name": "Comment les contraceptifs influencent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les contraceptifs hormonaux peuvent augmenter le risque de thrombose, surtout chez les fumeuses."
}
},
{
"@type": "Question",
"name": "Quel impact a l'hypertension sur le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension peut endommager les vaisseaux sanguins, augmentant le risque de thrombose."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/03/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Department of Medicine, Veterans Administration San Diego Healthcare System, University of California, San Diego, San Diego, CA, United States.
6 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
4 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
4 publications dans cette catégorie
Affiliations :
Immunological Diagnosis, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
4 publications dans cette catégorie
Affiliations :
Center for Genomic & Regenerative Medicine, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
3 publications dans cette catégorie
Affiliations :
Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, USA.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
3 publications dans cette catégorie
Affiliations :
An-Najah Center for Cancer and Stem Cell Research, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus P.O. Box 7, Palestine.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
3 publications dans cette catégorie
Affiliations :
Department of Hematology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Electronic address: radius@ims.u-tokyo.ac.jp.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
Center for Drug Research and Development, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
Center for Drug Research and Development, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Department of Clinical and Toxicological Analyses, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Biophysics, Umeå University, 90187 Umeå, Sweden.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Biophysics, Umeå University, 90187 Umeå, Sweden.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Biophysics, Umeå University, 90187 Umeå, Sweden.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Biophysics, Umeå University, 90187 Umeå, Sweden.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, USA.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Prometic Bioproduction, Laval, Quebec, Canada.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Kedrion S.p.A, Castelvecchio Pascoli, Barga (LU), Italy.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
W. M. Keck Center for Transgene Research, Notre Dame, IN, United States.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
W. M. Keck Center for Transgene Research, Notre Dame, IN, United States.
Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, United States.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba 279-0021, Japan.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
Perioperative medication management is vital to maintain patient safety while under anesthesia, as well as to avoid postoperative complications. Plastic surgeons make daily decisions on whether to ask...
A PubMed database search was conducted for articles through July 2021. The bibliographies of included studies were also examined for articles not acquired in the initial search queries. The authors in...
A total of 801 papers were identified by our search terms. After title and abstract screening, 35 papers were selected for full-text review. After full-text review, 20 papers were selected for inclusi...
The perioperative medication management in elective plastic surgery procedures remains a complex and multidisciplinary process. It is important to manage these patients in a case-by-case manner and to...
To identify and describe unusual soft tissue complications of periodontal plastic surgery procedures at the recipient site after periodontal grafts....
Two independent reviewers performed a comprehensive search in MEDLINE, Cochrane, periodontics journals, reference lists, and grey literature for articles dated up to July 2021. Publications related to...
A total of 1434 articles were examined, of which 28 met the inclusion criteria: one RCT, two cohort studies, and twenty-five case reports/series. The periodontal plastic surgery procedures described i...
Bone exostosis and epithelial inclusions were the most prevalent unusual complications following treatment with subepithelial connective tissue graft, free gingival graft, and acellular dermal matrix ...
Clinicians need to know the main complications that can occur in mucogingival surgeries as well as their clinical management to provide a successful and predictable treatment....
Anti-inflammatory drugs are commonly used to lower inflammation which is linked to a variety of disorders. It acts by inhibiting cyclooxygenase-mediated prostaglandin synthesis at the molecular level....
The relevant studies were searched in PubMed and screened based on inclusion and exclusion criteria. The quality of full-text studies was assessed using suitable Newcastle-Ottawa Scale. The overall es...
The overall estimate measures [OR 1.01 (0.50, 2.06)] have shown non-significant risk of hematoma with use of anti-inflammatory drugs in plastic surgery as compared to non-anti-inflammatory drugs. The ...
Based on available data, there is no significant risk of hematoma with use of anti-inflammatory drugs in plastic surgery....
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Inst...
Cosmetic facial surgical procedures have become increasingly popular. Previous studies have shown an association between Internet searches for and volume of these procedures being performed. There is ...
Google Trends, a tool that collects and analyzes the results from Google, was used to identify the average search volumes of popular facial plastic surgery procedures between 2004 and 2020. The identi...
There were very weak to moderate correlations between relative search volume (RSV), the ratio of a query's search volume to the sum of the total search volume over a given time period, of procedures w...
This study showed that RSV for common cosmetic plastic surgery procedures did not significantly correlate with the number of procedures performed annually in the United States. More research is needed...
In recent years surgical robotic systems which were specifically developed for microsurgery have expanded the application of robotic-assisted surgery to plastic reconstructive surgery. Currently, ther...
Price transparency allows patients to estimate surgical procedure costs, which can affect where they elect to receive care and should theoretically result in hospitals setting lower and more uniform p...
This study included 54 randomly chosen public and private hospitals. Pricing information for 15 common plastic surgery-related procedures was compiled from their websites....
One year after the ruling went into effect, only 13% of hospitals were fully compliant with Centers for Medicare & Medicaid Services requirements for reporting standard charges. The most commonly repo...
A comparative analysis of published prices provides a starting point for surgeons to recommend facilities to patients based on price. However, significant variability was observed in data presentation...
Microsurgical free tissue transfer has been successfully implemented for various reconstructive applications in children. The goal of this study was to identify the best available evidence on perioper...
A systematic review was conducted in the PubMed, Embase, Scopus, and Cochrane Library databases. Because a preliminary search of the pediatric microsurgical literature yielded scant data with a low le...
Two hundred four articles were identified, and 53 met inclusion criteria. Management approaches specific to the pediatric population were used to formulate recommendations. High-quality data were foun...
Pediatric-specific guidelines are important, as they acknowledge physiologic differences in children, which may be overlooked when extrapolating from adult studies. These evidence-based recommendation...
Although robotic surgery has been routinely established in other surgical disciplines, robotic technologies have been less readily adopted in plastic surgery. Despite a strong demand for innovation an...
Scientific leadership among women and underrepresented minorities is lacking in plastic surgery. It is unknown whether the underrepresentation of women and ethnic minorities extends into academic conf...
A retrospective analysis of all presentations from seven national and regional plastic surgery meetings between 2014 and 2018 was conducted. Gender, ethnicity, and academic rank of the first authors w...
A total of 4180 abstracts were presented by 3452 first authors. The majority of first authors were of European descent (53%), male (65%), and most commonly a resident physician (42%). Women were found...
Collectively, we present multilevel data that show a promising trend of increased female representation at national meetings. However, there appears to be a decline in ethnic diversity....
Many facial plastic and reconstructive surgery providers are interested in incorporating clinical trials into their own practice. Clinical trials in facial plastics have made key contributions to curr...